3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma, Follicular
3
Lymphoma, B-Cell
3
Lymphoma, Mantle-Cell
2
Lymphoma
2
Waldenstrom Macroglobulinemia
1
Recurrence
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Burkitt Lymphoma
1
Interventions
Cyclophosphamide
160
Rituximab
82
Peripheral Blood Stem Cell Transplantation
78
fludarabine phosphate
75
Etoposide
69
Filgrastim
67
Methotrexate
59
Cytarabine
58
Vincristine
50
Mycophenolic Acid
50
Whole-Body Irradiation
48
Radiotherapy
43
Cyclosporine
43
Busulfan
42
Tacrolimus
40
Melphalan
39
Dexamethasone
37
Prednisone
36
Doxorubicin
36
Antilymphocyte Serum
36
fludarabine
31
blinatumomab
27
Methylprednisolone
24
Granulocyte Colony-Stimulating Factor
22
Carmustine
22
Cord Blood Stem Cell Transplantation
21
Calcium Dobesilate
18
CT-P10
18
Inotuzumab Ozogamicin
16
sargramostim
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Burkitt Lymphoma
×
loncastuximab tesirine
×
Clear all
NCT05270057
2025-10-09
LONCA
Medical College of Wisconsin
Phase 1
Active not recruiting
11 enrolled